Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the target of a large drop in short interest in October. As of October 15th, there was short interest totalling 1,530,000 shares, a drop of 24.6% from the September 30th total of 2,030,000 shares. Based on an average daily volume of 1,100,000 shares, the short-interest ratio […]
Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) was the recipient of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 673,000 shares, a growth of 25.4% from the August 31st total of 536,500 shares. Based on an average daily trading volume, of 609,800 […]
Cardiff Oncology, Inc. (NASDAQ:CRDF – Get Free Report) saw a significant decline in short interest in August. As of August 31st, there was short interest totalling 536,500 shares, a decline of 19.5% from the August 15th total of 666,400 shares. Based on an average trading volume of 569,500 shares, the short-interest ratio is presently 0.9 […]
Cardiff Oncology (NASDAQ:CRDF – Get Free Report) and Allena Pharmaceuticals (NASDAQ:ALNAQ – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, risk, valuation, analyst recommendations, profitability, institutional ownership and earnings. Institutional & Insider Ownership 13.4% of Cardiff […]
Cardiff Oncology (NASDAQ:CRDF – Free Report) had its target price trimmed by HC Wainwright from $14.00 to $13.00 in a report issued on Tuesday morning, MarketBeat.com reports. The firm currently has a buy rating on the stock. Cardiff Oncology Price Performance Shares of NASDAQ:CRDF opened at $2.07 on Tuesday. The business’s fifty day moving average […]